All Publications Citing Use of MCE Products

• J Exp Clin Cancer Res. 2020 Jun 16;39(1):113. Celecoxib, 3,3'-Diindolylmethane, Fasudil, Prostaglandin E2 purchased from MCE.

• J Exp Clin Cancer Res. 2020 Jun 23;39(1):119. Lexibulin, IL-6 Protein, Human (CHO) purchased from MCE.

• J Exp Clin Cancer Res. 2020 May 7;39(1):81. Estradiol cypionate purchased from MCE.

• J Exp Clin Cancer Res.  2020 Feb 5;39(1):29.  Anisomycin purchased from MCE.

• J Adv Resl. 2020 Feb 13;23:133-142. Forskolin purchased from MCE.

• J Exp Clin Cancer Res.  2020 Feb 28;39(1):44.  Cell Counting Kit-8 purchased from MCE.

• Arthritis Rheumatol. 2020 Jan;72(1):166-178. Resiquimod purchased from MCE.

• J Exp Clin Cancer Res.  2020 Jan 28;39(1):22.  Verteporfin, GANT 61, Wnt-C59 purchased from MCE.

• Arthritis Rheumatol. 2020 Jun;72(6):1003-1012. IFN alpha-IFNAR-IN-1 purchased from MCE.

• J Exp Clin Cancer Res.  2019 Dec 30;38(1):505.  RO4929097, SOST Protein, Mouse (HEK293, His) purchased from MCE.

• J Exp Clin Cancer Res.  2019 Nov 15;38(1):468.  P005091 purchased from MCE.

• J Allergy Clin Immunol. 2019 Oct;144(4):1036-1049. JNK-IN-7 purchased from MCE.

• J Allergy Clin Immunol. 2019 Oct;144(4):1130-1133.e8. Fezolinetant purchased from MCE.

• J Exp Clin Cancer Res. 2019 Sep 13;38(1):404. Ezetimibe, Forskolin, Itraconazole, Vismodegib purchased from MCE.

• J Exp Clin Cancer Res.  2019 Aug 22;38(1):370. BAY 11-7082, Fludarabine, AG490, KU-55933, C-176 purchased from MCE.

• Arthritis Rheumatol. 2019 Aug;71(8):1252-1264. NFAT Inhibitor-1 purchased from MCE.

• J Exp Clin Cancer Res.  2019 Aug 14;38(1):354.  Chloroquine phosphate, Fulvestrant, 3-Methyladenine purchased from MCE.

• J Exp Clin Cancer Res.  2019 Aug 19;38(1):362. BAY 11-7082 purchased from MCE.

• J Exp Clin Cancer Res.  2019 Aug 14;38(1):353.  5-Fluorouracil, Doxorubicin purchased from MCE.

• J Exp Clin Cancer Res.  2019 Jul 10;38(1):300.  Elaidic acid, Oleic acid purchased from MCE.

• J Exp Clin Cancer Res.  2019 Jul 15;38(1):310. GW4869 purchased from MCE.

• J Exp Clin Cancer Res.  2019 Jul 5;38(1):289.  Napabucasin purchased from MCE.

• J Exp Clin Cancer Res.  2019 Jul 24;38(1):329.  Cell Counting Kit-8 purchased from MCE.

• J Exp Clin Cancer Res.  2019 Jul 17;38(1):315.  Cell Counting Kit-8 purchased from MCE.

• J Allergy Clin Immunol. 2019 Jun;143(6):2038-2051.e12. Decitabine purchased from MCE.

• J Exp Clin Cancer Res.  2019 May 23;38(1):219.  PD98059, Osimertinib, IL-13R alpha 1 Protein, Human (HEK293, His) purchased from MCE.

• J Exp Clin Cancer Res.  2019 May 29;38(1):228.  Fatostatin purchased from MCE.

• J Exp Clin Cancer Res.  2019 May 22;38(1):214. Trastuzumab purchased from MCE.

• J Exp Clin Cancer Res. 2019 May 15;38(1):197. SC79 purchased from MCE.

• J Exp Clin Cancer Res.  2019 May 27;38(1):221.  SCH772984 purchased from MCE.

• J Exp Clin Cancer Res. 2019 May 28;38(1):224. Cell Counting Kit-8 purchased from MCE.

• J Exp Clin Cancer Res.  2019 Apr 25;38(1):174.  Zenidolol hydrochloride, Isoprenaline hydrochloride purchased from MCE.

• J Allergy Clin Immunol. 2019 Mar;143(3):1100-1107.e11. Ibrutinib purchased from MCE.

• J Exp Clin Cancer Res.  2019 Mar 15;38(1):129.  Gefitinib, Osimertinib purchased from MCE.

• J Exp Clin Cancer Res. 2019 Mar 15;38(1):129. Gefitinib, Osimertinib purchased from MCE.

• J Adv Res. 2019 Feb 28;18:137-145. U0126-EtOH purchased from MCE.

• J Exp Clin Cancer Res.  2019 Feb 14;38(1):80. Sodium stibogluconate purchased from MCE.

• J Exp Clin Cancer Res.  2019 Feb 13;38(1):76. MK-2206 dihydrochloride, SMIP004 purchased from MCE.

• J Exp Clin Cancer Res.  2019 Feb 20;38(1):90. RRx-001 purchased from MCE.

• J Exp Clin Cancer Res.  2019 Feb 26;38(1):101. MG-132, Cycloheximide purchased from MCE.

• J Exp Clin Cancer Res.  2019 Feb 18;38(1):86.  Ibrutinib purchased from MCE.

• J Exp Clin Cancer Res.  2019 Feb 15;38(1):83. Cycloheximide purchased from MCE.

• J Exp Clin Cancer Res.  2019 Jan 31;38(1):44.  EN460 purchased from MCE.

• J Exp Clin Cancer Res. 2018 Dec 20;37(1):321. ML385, Stattic, Topotecan purchased from MCE.

• J Exp Clin Cancer Res.  2018 Nov 27;37(1):287.  Cisplatin, Purmorphamine, MG-132, Cycloheximide, TNF-alpha/TNFSF2 Protein, Rat (P.pastoris) purchased from MCE.

• J Exp Clin Cancer Res.  2018 Nov 29;37(1):295. GSK1292263, Sorafenib, MBX-2982, Gefitinib purchased from MCE.

• J Exp Clin Cancer Res.  2018 Nov 29;37(1):294.  Crystal Violet purchased from MCE.

• J Exp Clin Cancer Res.  2018 Nov 28;37(1):292. Protease Inhibitor Cocktail (EDTA-Free, 100× in DMSO) purchased from MCE.

• J Exp Clin Cancer Res. 2018 Oct 3;37(1):240. MG-132 purchased from MCE.

• J Exp Clin Cancer Res.  2018 Oct 29;37(1):261.  Apigenin, Curcumin purchased from MCE.